229 related articles for article (PubMed ID: 29374824)
1. Central Nervous System Involvement in Peripheral T Cell Lymphoma.
Chihara D; Oki Y
Curr Hematol Malig Rep; 2018 Feb; 13(1):1-6. PubMed ID: 29374824
[TBL] [Abstract][Full Text] [Related]
2. Central nervous system involvement in T-cell lymphoma: A single center experience.
Gurion R; Mehta N; Migliacci JC; Zelenetz A; Moskowitz A; Lunning M; Moskowitz C; Hamlin P; Horwitz S
Acta Oncol; 2016 May; 55(5):561-6. PubMed ID: 27046135
[TBL] [Abstract][Full Text] [Related]
3. The risk of central nervous system relapses in patients with peripheral T-cell lymphoma.
Chihara D; Fanale MA; Miranda RN; Noorani M; Westin JR; Nastoupil LJ; Hagemeister FB; Fayad LE; Romaguera JE; Samaniego F; Turturro F; Lee HJ; Neelapu SS; Rodriguez MA; Wang M; Fowler NH; Davis RE; Medeiros LJ; Oki Y
PLoS One; 2018; 13(3):e0191461. PubMed ID: 29538376
[TBL] [Abstract][Full Text] [Related]
4. Central nervous system relapse in peripheral T-cell lymphomas: a Swedish Lymphoma Registry study.
Ellin F; Landström J; Jerkeman M; Relander T
Blood; 2015 Jul; 126(1):36-41. PubMed ID: 25957393
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and feasibility of autologous stem cell transplantation in patients with diffuse large B‑cell lymphoma with secondary central nervous system involvement.
Lee MY; Kim HS; Lee JY; Lim SH; Kang ES; Ko YH; Kim SJ; Kim WS
Int J Hematol; 2015 Dec; 102(6):678-88. PubMed ID: 26493833
[TBL] [Abstract][Full Text] [Related]
6. Hematopoietic stem cell transplantation in primary central nervous system lymphoma: a review of the literature.
Gaut D; Schiller GJ
Int J Hematol; 2019 Mar; 109(3):260-277. PubMed ID: 30671909
[TBL] [Abstract][Full Text] [Related]
7. Diagnosis, prevention and treatment of central nervous system involvement in peripheral t-cell lymphomas.
Zing N; Fischer T; Federico M; Chiattone C; Ferreri AJM
Crit Rev Oncol Hematol; 2021 Nov; 167():103496. PubMed ID: 34653598
[TBL] [Abstract][Full Text] [Related]
8. High Doses of Antimetabolites Followed by High-Dose Sequential Chemoimmunotherapy and Autologous Stem-Cell Transplantation in Patients With Systemic B-Cell Lymphoma and Secondary CNS Involvement: Final Results of a Multicenter Phase II Trial.
Ferreri AJ; Donadoni G; Cabras MG; Patti C; Mian M; Zambello R; Tarella C; Di Nicola M; D'Arco AM; Doa G; Bruno-Ventre M; Assanelli A; Foppoli M; Citterio G; Fanni A; Mulè A; Caligaris-Cappio F; Ciceri F
J Clin Oncol; 2015 Nov; 33(33):3903-10. PubMed ID: 26282634
[TBL] [Abstract][Full Text] [Related]
9. Updates on Primary Central Nervous System Lymphoma.
Schaff LR; Grommes C
Curr Oncol Rep; 2018 Feb; 20(2):11. PubMed ID: 29492682
[TBL] [Abstract][Full Text] [Related]
10. Peripheral T-Cell Lymphomas Involving the Central Nervous System: A Report From the Czech Lymphoma Study Group Registry.
Mocikova H; Pytlík R; Benesova K; Janikova A; Duras J; Sykorova A; Steinerova K; Prochazka V; Campr V; Belada D; Trneny M
Front Oncol; 2022; 12():874462. PubMed ID: 35646641
[TBL] [Abstract][Full Text] [Related]
11. Primary and secondary central nervous system mature T- and NK-cell lymphomas.
Pang Y; Chihara D
Semin Hematol; 2021 Apr; 58(2):123-129. PubMed ID: 33906722
[TBL] [Abstract][Full Text] [Related]
12. Peripheral T-cell lymphoma: the role of hematopoietic stem cell transplantation.
Gkotzamanidou M; Papadimitriou CA
Crit Rev Oncol Hematol; 2014 Feb; 89(2):248-61. PubMed ID: 24075060
[TBL] [Abstract][Full Text] [Related]
13. Haematopoietic stem cell transplantation for treatment of primary CNS lymphoma: single-centre experience and literature review.
Bojic M; Berghoff AS; Troch M; Agis H; Sperr WR; Widhalm G; Wöhrer A; Kalhs P; Preusser M; Rabitsch W
Eur J Haematol; 2015 Jul; 95(1):75-82. PubMed ID: 25546348
[TBL] [Abstract][Full Text] [Related]
14. Therapy of primary CNS lymphoma: role of intensity, radiation, and novel agents.
Ferreri AJM
Hematology Am Soc Hematol Educ Program; 2017 Dec; 2017(1):565-577. PubMed ID: 29222306
[TBL] [Abstract][Full Text] [Related]
15. Central Nervous System Lymphoma.
Schaff L
Continuum (Minneap Minn); 2023 Dec; 29(6):1710-1726. PubMed ID: 38085895
[TBL] [Abstract][Full Text] [Related]
16. [Liposomal cytarabine in prophylaxis of the central nervous system involvement in rare aggresive lymphomas].
Kumiega B; Jurczak W; Fornagiel S; Dzietczenia J; Skotnicki AB
Przegl Lek; 2013; 70(4):187-90. PubMed ID: 23991555
[TBL] [Abstract][Full Text] [Related]
17. Central Nervous System Lymphoma.
Chukwueke UN; Nayak L
Hematol Oncol Clin North Am; 2019 Aug; 33(4):597-611. PubMed ID: 31229157
[TBL] [Abstract][Full Text] [Related]
18. Primary Central Nervous System Lymphoma.
Han CH; Batchelor TT
Continuum (Minneap Minn); 2017 Dec; 23(6, Neuro-oncology):1601-1618. PubMed ID: 29200113
[TBL] [Abstract][Full Text] [Related]
19. Salvage chemoimmunotherapy with rituximab, ifosfamide and etoposide (R-IE regimen) in patients with primary CNS lymphoma relapsed or refractory to high-dose methotrexate-based chemotherapy.
Mappa S; Marturano E; Licata G; Frezzato M; Frungillo N; Ilariucci F; Stelitano C; Ferrari A; Sorarù M; Vianello F; Baldini L; Proserpio I; Foppoli M; Assanelli A; Reni M; Caligaris-Cappio F; Ferreri AJ
Hematol Oncol; 2013 Sep; 31(3):143-50. PubMed ID: 23161567
[TBL] [Abstract][Full Text] [Related]
20. Primary Central Nervous System Lymphoma-PART 2: Modern Therapeutic Management and Future Directions.
Lukas RV; Gondi V; Stupp R; Raizer JJ
Oncology (Williston Park); 2018 Feb; 32(2):e11-e19. PubMed ID: 29492949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]